Medizinische Universität Graz - Research portal
Selected Publication:
Wolf, G; Aigner, RM; Schwarz, T; Nicoletti, R.
Diagnosis of metastasis of malignant melanoma in the thyroid gland with f18-FDG PET scan].
Hautarzt. 2002; 53(5):332-333
Doi: 10.1007/s001050100264
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
- Co-authors Med Uni Graz
- Aigner Reingard
- Nicoletti Rudolf
- Schwarz Thomas
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Metastases in the thyroid gland are very rare. When they occur, long-term survival is dismal; thus an early diagnosis is critical. Malignant melanoma is one of the tumors which may metastasize to the thyroid gland. Therefore we wanted to demonstrate F18-Fluorodeoxyglucose-Positron emission tomography (F18-FDG-PET) is a sensitive and reliable method to identify such metastases. We report about a 51-year-old man, who had an inguinal lymph node metastasis of a malignant melanoma with unknown primary tumor site. He came to us for an a follow-up F18-FDG-PET investigation. In the PET there was a pathologic FDG-uptake in the left lobe of the thyroid gland. The nodule was removed and showed a malignant melanoma metastasis. This unusual scenario underscores the value of the PET in the oncologic follow-up of patients with malignant melanoma.
- Find related publications in this database (using NLM MeSH Indexing)
- Diagnosis, Differential -
- Fluorodeoxyglucose F18 - diagnostic use
- Humans -
- Male -
- Melanoma - radionuclide imaging Melanoma - secondary
- Middle Aged -
- Skin Neoplasms - radionuclide imaging
- Thyroid Neoplasms - radionuclide imaging Thyroid Neoplasms - secondary
- Tomography, Emission-Computed -
- Find related publications in this database (Keywords)
- malignant melanoma
- thyroid gland
- metastasis
- FDG-PET